GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $88,451 | -3.1% | 46,068 | -27.3% | 0.00% | – |
| Q2 2023 | $91,274 | -47.7% | 63,385 | -23.8% | 0.00% | – |
| Q1 2023 | $174,571 | +11.4% | 83,129 | -40.1% | 0.00% | – |
| Q4 2022 | $156,740 | -61.6% | 138,708 | -44.5% | 0.00% | – |
| Q3 2022 | $408,000 | +67.9% | 250,085 | +35.0% | 0.00% | – |
| Q2 2022 | $243,000 | -59.5% | 185,227 | -50.3% | 0.00% | – |
| Q1 2022 | $600,000 | -67.5% | 372,660 | -58.2% | 0.00% | – |
| Q4 2021 | $1,848,000 | -25.3% | 892,310 | +39.9% | 0.00% | – |
| Q3 2021 | $2,475,000 | +96.3% | 637,920 | +61.9% | 0.00% | – |
| Q2 2021 | $1,261,000 | +258.2% | 394,010 | +142.6% | 0.00% | – |
| Q1 2021 | $352,000 | -73.3% | 162,397 | -72.4% | 0.00% | – |
| Q4 2020 | $1,318,000 | +69.0% | 589,288 | +101.8% | 0.00% | – |
| Q3 2020 | $780,000 | +12.4% | 292,008 | +28.7% | 0.00% | – |
| Q2 2020 | $694,000 | +49.9% | 226,841 | -3.9% | 0.00% | – |
| Q1 2020 | $463,000 | -52.9% | 236,146 | -31.3% | 0.00% | – |
| Q4 2019 | $983,000 | -29.5% | 343,677 | -9.6% | 0.00% | – |
| Q3 2019 | $1,394,000 | -84.5% | 380,061 | -82.4% | 0.00% | -100.0% |
| Q2 2019 | $8,979,000 | +93.0% | 2,163,628 | +137.6% | 0.00% | -50.0% |
| Q1 2019 | $4,653,000 | +154.7% | 910,569 | +70.9% | 0.00% | – |
| Q4 2018 | $1,827,000 | -65.8% | 532,809 | -40.1% | 0.00% | -100.0% |
| Q3 2018 | $5,347,000 | +22.5% | 889,608 | +29.6% | 0.00% | -50.0% |
| Q2 2018 | $4,366,000 | +340.6% | 686,393 | +228.2% | 0.00% | – |
| Q1 2018 | $991,000 | +84.2% | 209,165 | +29.9% | 0.00% | – |
| Q4 2017 | $538,000 | -18.0% | 161,075 | -47.9% | 0.00% | – |
| Q3 2017 | $656,000 | +14.3% | 309,248 | +32.6% | 0.00% | – |
| Q2 2017 | $574,000 | +331.6% | 233,146 | +304.8% | 0.00% | – |
| Q1 2017 | $133,000 | +209.3% | 57,600 | +31.5% | 0.00% | – |
| Q4 2016 | $43,000 | -52.2% | 43,800 | -44.8% | 0.00% | – |
| Q3 2016 | $90,000 | +91.5% | 79,300 | +147.8% | 0.00% | – |
| Q2 2016 | $47,000 | -31.9% | 32,000 | -33.7% | 0.00% | – |
| Q1 2016 | $69,000 | -42.0% | 48,250 | -33.5% | 0.00% | – |
| Q4 2015 | $119,000 | +52.6% | 72,610 | +118.7% | 0.00% | – |
| Q3 2015 | $78,000 | -88.9% | 33,200 | -87.1% | 0.00% | – |
| Q2 2015 | $705,000 | +120.3% | 258,131 | +170.4% | 0.00% | – |
| Q1 2015 | $320,000 | -69.3% | 95,469 | -68.3% | 0.00% | – |
| Q4 2014 | $1,044,000 | -51.5% | 300,865 | -29.7% | 0.00% | – |
| Q3 2014 | $2,153,000 | -61.0% | 428,073 | +7.2% | 0.00% | -100.0% |
| Q2 2014 | $5,516,000 | -58.0% | 399,330 | -53.5% | 0.00% | -66.7% |
| Q1 2014 | $13,147,000 | +1175.2% | 858,711 | +573.3% | 0.01% | – |
| Q4 2013 | $1,031,000 | +405.4% | 127,546 | +522.2% | 0.00% | – |
| Q3 2013 | $204,000 | – | 20,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 129,488 | $248,617 | 0.07% |
| Geneos Wealth Management Inc. | 417,350 | $801,312 | 0.04% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $23,040 | 0.02% |
| RETIREMENT GUYS FORMULA LLC | 11,500 | $22,080 | 0.02% |
| Vivaldi Capital Management LP | 19,261 | $36,981 | 0.01% |
| OSAIC HOLDINGS, INC. | 3,275,192 | $6,288,345 | 0.01% |
| Traynor Capital Management, Inc. | 34,707 | $66,638 | 0.01% |
| Atria Wealth Solutions, Inc. | 259,800 | $498,816 | 0.01% |
| BARRETT & COMPANY, INC. | 4,984 | $9,569 | 0.01% |
| Wealthspire Advisors, LLC | 183,862 | $353,016 | 0.01% |